Merck

In boon for Pfizer and Merck, CDC panel backs expanded use of pneumococcal vaccines
Fierce Pharma
Wed, 10/23/24 - 10:35 pm
Pfizer
Merck
pneumococcal disease
CDC
vaccines
Merck sets sights on brain cancer with $30M Modifi acquisition
Fierce Biotech
Wed, 10/23/24 - 11:41 am
Merck
M&A
Modifi Biosciences
glioblastoma
brain cancer
Gilead, Merck say HIV combo could be weekly, oral HIV drug
Pharmaphorum
Mon, 10/21/24 - 09:35 am
Gilead Sciences
Merck
HIV
antiretrovirals
clinical trials
islatravir
Sunleca
Merck's RSV antibody for infants shows over 60% efficacy in mid-late-stage study
Reuters
Thu, 10/17/24 - 08:39 pm
Merck
clesrovimab
RSV
clinical trials
infants
Ivonescimab Looking to Rival Merck’s Keytruda in NSCLC with Phase III Trial Enrollment Complete
Xtalks
Thu, 10/10/24 - 10:02 am
Summit Therapeutics
ivonescimab
non-small cell lung cancer
clinical trials
Merck
Keytruda
Merck's Keytruda stages comeback in head and neck cancer with trial win in earlier-stage disease
Fierce Pharma
Tue, 10/8/24 - 11:19 am
Merck
clinical trials
Keytruda
head and neck cancer
Merck bags options on Evaxion's AI-designed vaccines, offering small upfront and big back end
Fierce Biotech
Thu, 09/26/24 - 11:23 am
Merck
Evaxion Biotech
vaccines
artificial intelligence
Cancer and diabetes drugs expected to dominate 2025 Medicare negotiations under IRA
BioSpace
Wed, 09/25/24 - 12:08 pm
Inflation Reduction Act
CMS
drug pricing
Pfizer
Merck
Bristol Myers Squibb
cancer
diabetes
Merck's Keytruda-LAG-3 combo fails to tame tough colorectal cancer in phase 3
Fierce Biotech
Wed, 09/25/24 - 11:47 am
Merck
metastatic colorectal cancer
Keytruda
Keytruda beaten by Summit’s bispecific in NSCLC
Clinical Trials Arena
Fri, 09/20/24 - 11:15 am
Summit Therapeutics
Akeso
Merck
clinical trials
ivonescimab
Keytruda
non-small cell lung cancer
FDA Approves Merck’s Keytruda for First-Line Treatment of Pleural Mesothelioma
BioSpace
Wed, 09/18/24 - 11:16 pm
Merck
Keytruda
mesothelioma
FDA
Daiichi Sankyo-Merck's 'guided-missile' cancer drug meets main goal in late-stage trial
Reuters
Tue, 09/17/24 - 09:51 am
Daiichi Sankyo
Merck
patritumab deruxtecan
clinical trials
non-small cell lung cancer
ESMO: Despite checkered past, Merck's Keytruda-Lenvima pairing looks to change practice in liver cancer subtype
Fierce Pharma
Sun, 09/15/24 - 06:30 pm
ESMO
Merck
Eisai
Keytruda
Lenvima
liver cancer
ESMO: Despite positive trial, Merck's Welireg still comes up short in overall survival
Fierce Pharma
Fri, 09/13/24 - 11:12 am
Merck
Welireg
renal cell carcinoma
Novartis
Afinitor
ESMO
clinical trials
Merck, Daiichi repeat early success in small cell lung cancer with updated ADC data
Fierce Biotech
Mon, 09/9/24 - 11:30 am
Merck
Daiichi Sankyo
I-DXd
small cell lung cancer
clinical trials
Summit lung cancer drug shows ‘striking’ benefit over Keytruda
BioPharma Dive
Sun, 09/8/24 - 11:32 pm
Summit Therapeutics
Merck
Keytruda
clinical trials
non-small cell lung cancer
Merck and EyeBio launch trial of Restoret for diabetic macular edema
Clinical Trials Arena
Thu, 09/5/24 - 11:33 am
Merck
EyeBio
diabetic macular edema
diabetes
Restoret
Big Pharma is often media shy. Merck’s chief comms officer is hoping to change that.
Pharma Voice
Thu, 09/5/24 - 11:29 am
Merck
media
communications
Regeneron joins Koneksa Parkinson's digital biomarker study
Pharmaphorum
Wed, 09/4/24 - 11:22 am
Regeneron
Koneska Health
digital biomarkers
Parkinson's Disease
Merck
Merck’s Keytruda flunks pivotal studies in early-stage lung and skin cancers
Fierce Pharma
Thu, 08/29/24 - 11:15 am
Merck
Keytruda
non-small cell lung cancer
clinical trials
cutaneous squamous cell carcinoma

Pages